News
Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...
Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as ...
A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...
The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.
Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results